1097 related articles for article (PubMed ID: 32776119)
21. Tanshinone IIA induces growth inhibition and apoptosis in gastric cancer in vitro and in vivo.
Chen J; Shi DY; Liu SL; Zhong L
Oncol Rep; 2012 Feb; 27(2):523-8. PubMed ID: 22038415
[TBL] [Abstract][Full Text] [Related]
22. Tanshinone IIA inhibits osteosarcoma growth through modulation of AMPK-Nrf2 signaling pathway.
Xie Z; He B; Jiang Z; Zhao L
J Recept Signal Transduct Res; 2020 Dec; 40(6):591-598. PubMed ID: 32496906
[TBL] [Abstract][Full Text] [Related]
23. Tanshinone IIA induced cell death via miR30b-p53-PTPN11/SHP2 signaling pathway in human hepatocellular carcinoma cells.
Ren X; Wang C; Xie B; Hu L; Chai H; Ding L; Tang L; Xia Y; Dou X
Eur J Pharmacol; 2017 Feb; 796():233-241. PubMed ID: 27894814
[TBL] [Abstract][Full Text] [Related]
24. Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo.
Chiu SC; Huang SY; Chen SP; Su CC; Chiu TL; Pang CY
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):315-22. PubMed ID: 24042854
[TBL] [Abstract][Full Text] [Related]
25. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling.
Fu D; Wang C; Yu L; Yu R
Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
[TBL] [Abstract][Full Text] [Related]
26. Tanshinone IIA down-regulates the protein expression of ErbB-2 and up-regulates TNF-alpha in colon cancer cells in vitro and in vivo.
Su CC; Lin YH
Int J Mol Med; 2008 Dec; 22(6):847-51. PubMed ID: 19020785
[TBL] [Abstract][Full Text] [Related]
27. Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer.
Zhang YZ; Lai HL; Huang C; Jiang ZB; Yan HX; Wang XR; Xie C; Huang JM; Ren WK; Li JX; Zhai ZR; Yao XJ; Wu QB; Leung EL
Phytomedicine; 2024 Jun; 128():155431. PubMed ID: 38537440
[TBL] [Abstract][Full Text] [Related]
28. The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG.
Lv C; Zeng HW; Wang JX; Yuan X; Zhang C; Fang T; Yang PM; Wu T; Zhou YD; Nagle DG; Zhang WD
Cell Death Dis; 2018 Feb; 9(2):165. PubMed ID: 29416003
[TBL] [Abstract][Full Text] [Related]
29. Tanshinone IIA Activates Nuclear Factor-Erythroid 2-Related Factor 2 to Restrain Pulmonary Fibrosis via Regulation of Redox Homeostasis and Glutaminolysis.
An L; Peng LY; Sun NY; Yang YL; Zhang XW; Li B; Liu BL; Li P; Chen J
Antioxid Redox Signal; 2019 May; 30(15):1831-1848. PubMed ID: 30105924
[TBL] [Abstract][Full Text] [Related]
30. Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential.
Chiu TL; Su CC
Int J Mol Med; 2010 Feb; 25(2):231-6. PubMed ID: 20043132
[TBL] [Abstract][Full Text] [Related]
31. Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer.
Lu Q; Zhang P; Zhang X; Chen J
Int J Mol Med; 2009 Dec; 24(6):773-80. PubMed ID: 19885617
[TBL] [Abstract][Full Text] [Related]
32. Baicalin enhances the chemotherapy sensitivity of oxaliplatin-resistant gastric cancer cells by activating p53-mediated ferroptosis.
Shao L; Zhu L; Su R; Yang C; Gao X; Xu Y; Wang H; Guo C; Li H
Sci Rep; 2024 May; 14(1):10745. PubMed ID: 38730240
[TBL] [Abstract][Full Text] [Related]
33. Pseudolaric acid B triggers ferroptosis in glioma cells via activation of Nox4 and inhibition of xCT.
Wang Z; Ding Y; Wang X; Lu S; Wang C; He C; Wang L; Piao M; Chi G; Luo Y; Ge P
Cancer Lett; 2018 Aug; 428():21-33. PubMed ID: 29702192
[TBL] [Abstract][Full Text] [Related]
34. Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.
Liu H; Liu C; Wang M; Sun D; Zhu P; Zhang P; Tan X; Shi G
Sci Rep; 2021 Sep; 11(1):19268. PubMed ID: 34588580
[TBL] [Abstract][Full Text] [Related]
35. Actinidia chinensis Planch prevents proliferation and migration of gastric cancer associated with apoptosis, ferroptosis activation and mesenchymal phenotype suppression.
Gao Z; Deng G; Li Y; Huang H; Sun X; Shi H; Yao X; Gao L; Ju Y; Luo M
Biomed Pharmacother; 2020 Jun; 126():110092. PubMed ID: 32203890
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases.
Guo R; Li L; Su J; Li S; Duncan SE; Liu Z; Fan G
Drug Des Devel Ther; 2020; 14():4735-4748. PubMed ID: 33192051
[No Abstract] [Full Text] [Related]
37. Apatinib induced ferroptosis by lipid peroxidation in gastric cancer.
Zhao L; Peng Y; He S; Li R; Wang Z; Huang J; Lei X; Li G; Ma Q
Gastric Cancer; 2021 May; 24(3):642-654. PubMed ID: 33544270
[TBL] [Abstract][Full Text] [Related]
38. Tanshinone IIA induces cell death via Beclin-1-dependent autophagy in oral squamous cell carcinoma SCC-9 cell line.
Qiu Y; Li C; Wang Q; Zeng X; Ji P
Cancer Med; 2018 Feb; 7(2):397-407. PubMed ID: 29316373
[TBL] [Abstract][Full Text] [Related]
39. Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway.
Yu X; He Z; Wang Z; Ke S; Wang H; Wang Q; Li S
Exp Cell Res; 2024 May; 438(2):114053. PubMed ID: 38663476
[TBL] [Abstract][Full Text] [Related]
40. Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells.
Dai ZK; Qin JK; Huang JE; Luo Y; Xu Q; Zhao HL
J Nat Med; 2012 Jan; 66(1):192-201. PubMed ID: 21853384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]